136 related articles for article (PubMed ID: 23572277)
1. Expression of secreted frizzled-related protein 1 and 3, T-cell factor 1 and lymphoid enhancer factor 1 in clear cell renal cell carcinoma.
Nikuševa-Martić T; Serman L; Zeljko M; Vidas Z; Gašparov S; Zeljko HM; Kosović M; Pećina-Šlaus N
Pathol Oncol Res; 2013 Jul; 19(3):545-51. PubMed ID: 23572277
[TBL] [Abstract][Full Text] [Related]
2. Secreted frizzled-related protein 1 loss contributes to tumor phenotype of clear cell renal cell carcinoma.
Gumz ML; Zou H; Kreinest PA; Childs AC; Belmonte LS; LeGrand SN; Wu KJ; Luxon BA; Sinha M; Parker AS; Sun LZ; Ahlquist DA; Wood CG; Copland JA
Clin Cancer Res; 2007 Aug; 13(16):4740-9. PubMed ID: 17699851
[TBL] [Abstract][Full Text] [Related]
3. Expression and proliferation-promoting role of lymphoid enhancer-binding factor 1 in human clear cell renal carcinoma.
Shang D; Bi R; Han T; Wang D; Tian Y; Liu Y
Cancer Invest; 2014 Aug; 32(7):368-74. PubMed ID: 24897388
[TBL] [Abstract][Full Text] [Related]
4. 5-aza-2'-deoxycytidine enhances susceptibility of renal cell carcinoma to paclitaxel by decreasing LEF1/phospho-β-catenin expression.
Shang D; Liu Y; Xu X; Han T; Tian Y
Cancer Lett; 2011 Dec; 311(2):230-6. PubMed ID: 21880414
[TBL] [Abstract][Full Text] [Related]
5. Functional significance of secreted Frizzled-related protein 1 in metastatic renal cell carcinomas.
Saini S; Liu J; Yamamura S; Majid S; Kawakami K; Hirata H; Dahiya R
Cancer Res; 2009 Sep; 69(17):6815-22. PubMed ID: 19723665
[TBL] [Abstract][Full Text] [Related]
6. Role of secreted frizzled-related protein 3 in human renal cell carcinoma.
Hirata H; Hinoda Y; Ueno K; Majid S; Saini S; Dahiya R
Cancer Res; 2010 Mar; 70(5):1896-905. PubMed ID: 20160027
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-β1 enhances proliferative and metastatic potential by up-regulating lymphoid enhancer-binding factor 1/integrin αMβ2 in human renal cell carcinoma.
Liu Y; Shang D
Mol Cell Biochem; 2020 Feb; 465(1-2):165-174. PubMed ID: 31848806
[TBL] [Abstract][Full Text] [Related]
8. Frequent loss of SFRP1 expression in multiple human solid tumours: association with aberrant promoter methylation in renal cell carcinoma.
Dahl E; Wiesmann F; Woenckhaus M; Stoehr R; Wild PJ; Veeck J; Knüchel R; Klopocki E; Sauter G; Simon R; Wieland WF; Walter B; Denzinger S; Hartmann A; Hammerschmied CG
Oncogene; 2007 Aug; 26(38):5680-91. PubMed ID: 17353908
[TBL] [Abstract][Full Text] [Related]
9. The expression and function of Frizzled-7 in human renal cell carcinoma.
Xu R; Zeng S; Xie W; Sun C; Chen YL; Chen MJ; Zhang L
Clin Transl Oncol; 2016 Mar; 18(3):269-76. PubMed ID: 26243397
[TBL] [Abstract][Full Text] [Related]
10. Aberrant expression of SFRP1, SFRP3, DVL2 and DVL3 Wnt signaling pathway components in diffuse gastric carcinoma.
Sremac M; Paic F; Grubelic Ravic K; Serman L; Pavicic Dujmovic A; Brcic I; Krznaric Z; Nikuseva Martic T
Oncol Lett; 2021 Dec; 22(6):822. PubMed ID: 34691249
[TBL] [Abstract][Full Text] [Related]
11. Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma.
Suyama T; Furuya M; Nishiyama M; Kasuya Y; Kimura S; Ichikawa T; Ueda T; Nikaido T; Ito H; Ishikura H
Cancer; 2005 Jan; 103(2):258-67. PubMed ID: 15578685
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia-inducible factor 1 alpha in clear cell renal cell carcinoma.
Klatte T; Seligson DB; Riggs SB; Leppert JT; Berkman MK; Kleid MD; Yu H; Kabbinavar FF; Pantuck AJ; Belldegrun AS
Clin Cancer Res; 2007 Dec; 13(24):7388-93. PubMed ID: 18094421
[TBL] [Abstract][Full Text] [Related]
13. Expression of Tcf/Lef and sFrp and localization of beta-catenin in the developing mouse lung.
Tebar M; Destrée O; de Vree WJ; Ten Have-Opbroek AA
Mech Dev; 2001 Dec; 109(2):437-40. PubMed ID: 11731265
[TBL] [Abstract][Full Text] [Related]
14. BIGH3 is overexpressed in clear cell renal cell carcinoma.
Yamanaka M; Kimura F; Kagata Y; Kondoh N; Asano T; Yamamoto M; Hayakawa M
Oncol Rep; 2008 Apr; 19(4):865-74. PubMed ID: 18357369
[TBL] [Abstract][Full Text] [Related]
15. Expression of LEF1 and TCF1 (TCF7) proteins associates with clinical progression of nasopharyngeal carcinoma.
Zhan Y; Feng J; Lu J; Xu L; Wang W; Fan S
J Clin Pathol; 2019 Jun; 72(6):425-430. PubMed ID: 30918012
[TBL] [Abstract][Full Text] [Related]
16. The human T-cell factor-4 gene splicing isoforms, Wnt signal pathway, and apoptosis in renal cell carcinoma.
Shiina H; Igawa M; Breault J; Ribeiro-Filho L; Pookot D; Urakami S; Terashima M; Deguchi M; Yamanaka M; Shirai M; Kaneuchi M; Kane CJ; Dahiya R
Clin Cancer Res; 2003 Jun; 9(6):2121-32. PubMed ID: 12796377
[TBL] [Abstract][Full Text] [Related]
17. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).
Sun C; Song H; Zhang H; Hou C; Zhai T; Huang L; Zhang L
J Cancer Res Clin Oncol; 2012 Oct; 138(10):1619-24. PubMed ID: 22614155
[TBL] [Abstract][Full Text] [Related]
18. Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).
Baumunk D; Reichelt U; Hildebrandt J; Krause H; Ebbing J; Cash H; Miller K; Schostak M; Weikert S
World J Urol; 2013 Oct; 31(5):1191-6. PubMed ID: 22544372
[TBL] [Abstract][Full Text] [Related]
19. Cell-context dependent TCF/LEF expression and function: alternative tales of repression, de-repression and activation potentials.
Mao CD; Byers SW
Crit Rev Eukaryot Gene Expr; 2011; 21(3):207-36. PubMed ID: 22111711
[TBL] [Abstract][Full Text] [Related]
20. Expression of progranulin and the epithelin/granulin precursor acrogranin correlates with neoplastic state in renal epithelium.
Donald CD; Laddu A; Chandham P; Lim SD; Cohen C; Amin M; Gerton GL; Marshall FF; Petros JA
Anticancer Res; 2001; 21(6A):3739-42. PubMed ID: 11911241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
